Siolta Therapeutics
Siolta Therapeutics is a clinical-stage biotech company developing live biotherapeutic products targeting the core drivers of disease. They utilize a proprietary Precision Symbiotics Platform™ to advance programs into clinical and preclinical development, focusing on areas such as preventing atopic diseases in newborns and treating conditions like necrotizing enterocolitis.
Buy Funded Startups lists
Funding Round: Series C
Funding Amount: $12M
Date: 14-Mar-2024
Investors: SymBiosis, Khosla Ventures, TIME Ventures, Seventure (Health for Life Capital Fund), Global Brain (Kirin Health Innovation Fund/GB-VII)
Markets: Biotech, Therapeutics, Microbiome
HQ: San Carlos, California, United States
Founded: 2016
Website: https://www.sioltatherapeutics.com
LinkedIn: https://www.linkedin.com/company/siolta-therapeutics
Twitter: https://twitter.com/SioltaThera
Facebook: https://www.facebook.com/sioltatherapeutics
Crunchbase: https://www.crunchbase.com/organization/siolta-therapeutics
Leave a Comment
Comments
No comments yet.